71 related articles for article (PubMed ID: 579512)
1. Fibrinogen, fibrinogen degradation products and erythrocyte flexibility.
Rampling MW; Sirs JA
Thromb Haemost; 1977 Oct; 38(3):668-76. PubMed ID: 579512
[No Abstract] [Full Text] [Related]
2. The accelerating effect of fibrinogen and early fibrinogen degradation products on erythrocyte sedimentation.
Marsh NA
Thromb Haemost; 1979 Aug; 42(2):757-63. PubMed ID: 505378
[TBL] [Abstract][Full Text] [Related]
3. [Effect of fibrin degradation products on different biological tests (author's transl)].
Vila V; Aznar J; Regañon E
Sangre (Barc); 1976; 21(4):814-26. PubMed ID: 1006498
[No Abstract] [Full Text] [Related]
4. A functional plasminogen assay utilizing the potentiating effect of fibrinogen to correct for the overestimation of plasminogen in pathological plasma samples.
Gram J; Jespersen J
Thromb Haemost; 1985 Apr; 53(2):255-9. PubMed ID: 4024036
[TBL] [Abstract][Full Text] [Related]
5. Fibrinogen degradation products in fresh frozen plasma. Possible contribution to immunosuppression.
Donnell CA; Daniel SJ; Ferrara JJ
Am Surg; 1989 Aug; 55(8):505-7. PubMed ID: 2764399
[TBL] [Abstract][Full Text] [Related]
6. Biological effects of fibrinogen-fibrin degradation products.
Larrieu MJ; Dray L; Ardaillou N
Thromb Diath Haemorrh; 1975 Dec; 34(3):686-92. PubMed ID: 1108283
[No Abstract] [Full Text] [Related]
7. Influence of fibrin, fibrinogen and fibrinogen degradation products on cultured endothelial cells.
Watanabe K; Tanaka K
Atherosclerosis; 1983 Jul; 48(1):57-70. PubMed ID: 6882509
[TBL] [Abstract][Full Text] [Related]
8. Selective immobilization of alpha-thrombin by surface-bound fibrin.
Wilner GD; Danitz MP; Mudd MS; Hsieh KH; Fenton JW
J Lab Clin Med; 1981 Mar; 97(3):403-11. PubMed ID: 7462772
[No Abstract] [Full Text] [Related]
9. [Multidomain structure of fibrinogen and its transformations].
Rozenfel'd MA; Gershkovich KB
Izv Akad Nauk SSSR Biol; 1989; (2):219-25. PubMed ID: 2663952
[TBL] [Abstract][Full Text] [Related]
10. Permeability enhancing and chemotactic activities of lower molecular weight degradation products of human fibrinogen.
Sueishi K; Nanno S; Tanaka K
Thromb Haemost; 1981 Feb; 45(1):90-4. PubMed ID: 7245130
[TBL] [Abstract][Full Text] [Related]
11. Fibrinogen-fibrin degradation products.
Kwaan HC
Ann Clin Lab Sci; 1980; 10(3):234-7. PubMed ID: 7396389
[TBL] [Abstract][Full Text] [Related]
12. The stimulatory capacity of soluble fibrin prepared from high and low molecular weight fibrinogen on plasminogen activation.
Halvorsen S; Skjønsberg OH; Godal HC
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):133-7. PubMed ID: 8457641
[TBL] [Abstract][Full Text] [Related]
13. Fibrinogen fragments X, Y, D and E increase levels of plasma fibrinogen and liver mRNAs coding for fibrinogen polypeptides in rats.
Princen HM; Moshage HJ; Emeis JJ; de Haard HJ; Nieuwenhuizen W; Yap SH
Thromb Haemost; 1985 Apr; 53(2):212-5. PubMed ID: 4024030
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen, fibrin, and FDP induce C-reactive protein generation in rat vascular smooth muscle cells: pro-inflammatory effect on atherosclerosis.
Guo F; Liu J; Wang C; Liu N; Lu P
Biochem Biophys Res Commun; 2009 Dec; 390(3):942-6. PubMed ID: 19852936
[TBL] [Abstract][Full Text] [Related]
15. [Characteristics of the coagulative and immunological properties of fibrinogen degradation products].
Fedorova ZD; Paradeeva IK; Zhukova IV; Elizarova AI; Pshenichnaia LN
Probl Gematol Pereliv Krovi; 1980 Jan; 25(1):44-6. PubMed ID: 6768062
[No Abstract] [Full Text] [Related]
16. Effect of fibrinogen degradation products on the rat blood vessels.
Buczko W
Acta Physiol Pol; 1977; 28(2):153-9. PubMed ID: 868533
[TBL] [Abstract][Full Text] [Related]
17. [Determination of fibrin and fibrinogen split products by their anticoagulant activity].
Belitser VA; Varetskaia TV; Tsynkalovskaia SN; Tsariuk LA; Shevchenko LI
Ukr Biokhim Zh; 1976; 48(4):521-32. PubMed ID: 982623
[TBL] [Abstract][Full Text] [Related]
18. [Inhibition of fibrin monomer polymerization by fibrinolysis products--fragments D and DD].
Belitser VA; Platonova TN; Musialkovskaia AA
Dokl Akad Nauk SSSR; 1986; 291(4):1001-4. PubMed ID: 3803182
[No Abstract] [Full Text] [Related]
19. Interaction of Arvin with erythrocyte flexibility.
Myers P; Rampling MW; Sirs JA
J Physiol; 1973 Apr; 230(1):51P-52P. PubMed ID: 4702445
[No Abstract] [Full Text] [Related]
20. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
Scott WL; Francis CW; Knutson DW; Marder VJ
J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
